๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026

BIONET Therapeutics Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
211.96154.4881.325.37-
Revenue Growth
20.74%89.96%1414.60%--
Gross Profit
120.0161.652.021.8-
Operating Income
-86.78-116.45-99.36-39.26-12.53
Net Income
-69.24-97.43-86.26-37.34-12.52
Earnings Per Share
-0.99-1.39-1.50-2.47-11.43
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
1,0171,0601,215524.3253.97
Total Debt
22.5210.9---
Net Cash (Debt)
994.361,0491,215524.3253.97
Net Cash Growth
-1.30%-13.63%131.67%871.44%-
Net Cash Per Share
14.1914.9921.1534.7449.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-25.49-57.48-124.39-34.16-3.47
Capital Expenditures
-23.67-81.19-46.56-12.1-
Free Cash Flow
-49.16-138.68-170.95-46.26-3.47
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
56.62%39.91%2.48%33.49%-
Operating Margin
-40.94%-75.38%-122.19%-731.20%-
Pretax Margin
-32.67%-63.07%-106.07%-695.44%-
Profit Margin
-32.67%-63.07%-106.07%-695.44%-
FCF Margin
-23.19%-89.77%-210.22%-861.52%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
9.7825.4739.99--